Clinical Trial Update: A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for IVS-3001, an HLA-G-targeted CAR-T therapy, in previously treated advanced HLA-G-positive solid tumors; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IVS-3001

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING